Alexander Schuth

Alexander Schuth is the Chief Operating and Financial Officer at Denali Therapeutics since March 2015 and a Director on the Board of Directors at Molecular Health since November 2016. Previously, Alexander held the position of Head of Neuroscience Partnering at Genentech, Inc. from August 2005 to March 2015 and served as an Investment Banking Associate at Merrill Lynch from January 2001 to June 2003. Alexander earned an MBA from The Wharton School between 2003 and 2005 and holds a Doctor of Medicine degree from Humboldt-Universität zu Berlin, completed in 2000.